Ind-Swift Labs announces preferential issue outcome

Ind-Swift Labs announces outcome of preferential issue committee meeting. The decision follows a meeting held on September 4, 2026, as mandated under Regulation 30 of SEBI Listing Regulations. No financial figures or strategic changes were disclosed. The update is procedural in nature.

📊 STOCKS: $INDSWFTLAB | 🏢 SECTOR: Pharma | #LOWIMPACT #PreferentialIssue